Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease
NCT04749563
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Dementia of Alzheimer Type
Interventions
DRUG:
IGC AD1
DRUG:
Placebo
Sponsor
IGC Pharma, LLC